Zdrowie i gospodarka · 21/06/2024
FDA Releases Guidance on Demonstrating Bioequivalence for Poorly Soluble Medications
The FDA has released a final guidance for industry on demonstrating bioequivalence for generic medications that are poorly soluble in water and have limited systemic absorption, a process that can be challenging to study.